Free Trial
NASDAQ:BCTXW

BriaCell Therapeutics (BCTXW) Stock Price, News & Analysis

BriaCell Therapeutics logo
$0.10 -0.01 (-8.95%)
As of 10:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About BriaCell Therapeutics Stock (NASDAQ:BCTXW)

Key Stats

Today's Range
$0.08
$0.10
50-Day Range
$0.05
$0.17
52-Week Range
$0.02
$0.70
Volume
402 shs
Average Volume
90,122 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Receive BCTXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCTXW Stock News Headlines

BriaCell Therapeutics Corp. Wt
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
See More Headlines

BCTXW Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at $0.2895 on January 1st, 2025. Since then, BCTXW stock has decreased by 67.0% and is now trading at $0.0956.
View the best growth stocks for 2025 here
.

Shares of BCTXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BCTXW
Web
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:BCTXW) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners